Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|April 30, 2014
The Impact of HIPAA Laws on Electronic Adherence Tools
Gary Rice, RPh, MS, MBA, vice president of clinical services at Diplomat Specialty Pharmacy, discusses how HIPAA laws could change the use of electronic adherence tools.
Advertisement
Gary Rice, RPh, MS, MBA, vice president of clinical services at Diplomat Specialty Pharmacy, discusses how HIPAA laws could change the use of electronic adherence tools.
This video was shot at the 2013 Academy of Managed Care Pharmacy Nexus Meeting in San Antonio, Texas.
Advertisement
Related to this article
With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors
2
Expert Q&A: Pharmacists Address Pneumococcal Vaccine Hesitancy and Screening Complexity in Transitions of Care
3
Not So Rare After All: Pharmacists Weigh In on Diagnosing and Managing ATTR-CM
4
Enicepatide Meets Primary End Points in Phase 2 Trial of Adults With Type 2 Diabetes, Obesity
5